In accordance with many other studies, they could show, e.g., that, in iPSC-derived ECs from HPAH patients, reduced BMPR2 expression led to impaired canonical BMPR2 signalling (pSMAD1/5-ID1) in response to BMP treatment (Figure 3). The gene discussed is BMPR2; the disease is heritable pulmonary arterial hypertension.